Wells Fargo & Company »

Lenz Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $487k 10k 46.58
2025-06-30 $273k 9.3k 29.31
2025-03-31 $197k 7.7k 25.70
2024-12-31 $217k 7.5k 28.87
2024-09-30 $140k 5.9k 23.74
2024-06-30 $98k 5.6k 17.29
2024-03-31 $30k 1.4k 22.33